drugset / Trial / NCT03232125

Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

NCT03232125

Completed 54 enrolled Yonsei University
RandomizedParallel-groupTriple-blindPrevention

Summary

Intraperitoneal insufflation of carbon dioxide may affect the sympathetic activity that leads to changes in ventricular re-polarization. This in turn can result in changes of heart rate-corrected QT (QTc) interval. Ramosetron is a 5-hydroxytryptamine three receptor antagonist and widely used anti-emetics. However, QTc interval prolongation has been observed in a number of patients after administration of 5-HT3 receptor antagonists. The aim of this study is to evaluate the effects of ramosetron on QTc interval and possible cardiovascular adverse effects during robot-assisted laparoscopic prostatectomy with steep Trendelenburg position.

Timeline

Start
2017-08-01
Primary completion
2020-06-09
Completion
2020-06-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramosetron Small molecule 0.3 mg Intravenous

Indications